Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
Mar. 31, 2023
Jun. 30, 2022
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 232,004 $ 166,231
Revenues in excess of billings, allowance $ 43,334 $ 136,976
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 500,000 500,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 14,500,000 14,500,000
Common stock, shares issued 12,238,042 12,196,570
Common stock, shares outstanding 11,299,011 11,257,539
Treasury stock, shares 939,031 939,031